SCHEMBL23925729

SCHEMBL23925729

CCc1c(-c2ccccc2)oc(=O)c(O)c1CC(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 3/20 0.45
MCL1 Q07820 3/20 0.45
BAD Q92934 1/20 0.37
ELANE P08246 1/20 0.37
NR4A2 P43354 3/20 0.36
RXRA P19793 1/20 0.36
KDM4E B2RXH2 3/20 0.36
MEN1 O00255 2/20 0.36
LMNA P02545 2/20 0.36
TP53 P04637 2/20 0.36
CYP3A4 P08684 2/20 0.36
ALOX15 P16050 2/20 0.36
MAPK1 P28482 2/20 0.36
KMT2A Q03164 2/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
ABCB1 P08183 1/20 0.36
CALM1 P0DP23 1/20 0.36
AR P10275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23925826 0.84 MCL1 (0.49) BCL2MCL1BADELANENR4A2
SCHEMBL25144838 0.81 ELANE (0.44) ELANEKDM4EMEN1LMNATP53
SCHEMBL23925819 0.80 KDM4E (0.40) MCL1ELANEKDM4EMEN1LMNA
SCHEMBL23925781 0.78 MEN1 (0.39) KDM4EMEN1LMNATP53CYP3A4
SCHEMBL23940763 0.76 KDM4E (0.37) KDM4EMEN1LMNATP53CYP3A4
SCHEMBL25144976 0.70 ELANE (0.44) MCL1ELANEKDM4ELMNACYP3A4
SCHEMBL13545615 0.70 ABCG2 (0.41) KDM4EMEN1LMNATP53CYP3A4
SCHEMBL28788704 0.69 ABCG2 (0.56) KDM4EMEN1LMNATP53CYP3A4
SCHEMBL23940764 0.67 HPGD (0.42) KDM4EMEN1LMNATP53CYP3A4
SCHEMBL10869318 0.67 MEN1 (0.50) KDM4EMEN1LMNATP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2023-04-20 US disclosed
WO-2021211982-A2 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS CYP2B6, TYR, CYP2D6 BCL2 1018/4885MCL1 813/4885BAD 2252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.